Speaker illustration

Doctor Mariam Elmegaard

Gentofte University Hospital, Copenhagen (Denmark)

Member of:

European Society of Cardiology

Biochemical profiles and risk of cardiovascular events in patients withType 2 Diabetes: implications for choice of novel antihyperglycemic therapy

Event: ESC Congress 2023

Topic: Antidiabetic Pharmacotherapy

Session: Novel targets and treatments for heart diseases and diabetes


Adherence and discontinuation of sglt2-inhibitors and glp1-r agonists in patients with type 2 diabetes with and without cardiovascular disease

Event: ESC Congress 2022

Topic: Antidiabetic Pharmacotherapy

Session: Anti-diabetic pharmacotherapy in clinical practice


Risk of heart failure associated with thiazide diuretics compared with calcium channel blockers in patients with type 2 diabetes: a nationwide nested case-control study

Event: ESC Congress 2020

Topic: Prevention

Session: Pharmacological Interventions To Treat and Prevent Acute Heart Failure


Cardiovascular risk profiles and outcomes in patients with type 2 diabetes - Implications for choice of new diabetes therapies

Event: ESC Congress 2019

Topic: Epidemiology

Session: The right glucose-lowering drugs for the right patient


Development of heart failure in type 2 diabetes: ischemic heart disease, end stage renal disease or hypertension and diabetes? a nationwide cohort study

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Heart failure: the nemesis of Diabetes


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb